Form 8-K SEATTLE GENETICS INC For: Oct 01

Go back to Form 8-K SEATTLE GENETICS INC For: Oct 01

Seattle Genetics (SGEN) PT Raised to $105 at Leerink Partners

October 1, 2018 11:21 AM EDT

Leerink Partners analyst Andrew Berens raised the price target on Seattle Genetics (NASDAQ: SGEN) to $105.00 (from $101.00) while maintaining a Outperform rating.

Berens is raising Adcetris estimates on unanticsurvival surviable benefit.

... More